miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1.
Koutalianos D, Koutsoulidou A, Mytidou C, Kakouri AC, Oulas A, Tomazou M, Kyriakides TC, Prokopi M, Kapnisis K, Nikolenko N, Turner C, Lusakowska A, Janiszewska K, Papadimas GK, Papadopoulos C, Kararizou E, Spyrou GM, Gourdon G, Zamba Papanicolaou E, Gorman G, Anayiotos A, Lochmüller H, Phylactou LA.
Koutalianos D, et al. Among authors: anayiotos a.
Mol Ther Methods Clin Dev. 2021 Sep 14;23:169-183. doi: 10.1016/j.omtm.2021.09.007. eCollection 2021 Dec 10.
Mol Ther Methods Clin Dev. 2021.
PMID: 34703840
Free PMC article.